Grace Therapeutics (GRCE) Operating Income (2019 - 2026)
Grace Therapeutics (GRCE) recorded Operating Income of -$15.92 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$3.09 million a year earlier.
Powered by 
Analysis
Grace Therapeutics (GRCE) Operating Income (2019 - 2026) Analysis & Trends
On a TTM basis, Grace Therapeutics' Operating Income came in at -$23.91 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$11.08 million.
- Across earlier fiscal years, Operating Income came in at -$16.68 million in FY2025, -$12.85 million in FY2024, -$52.16 million in FY2023 and -$15.59 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Operating Income since fiscal Q4 2023.
- Per Business Quant, the preceding three fiscal quarters came in at -$3.01 million (Q4 2026), -$2.45 million (Q3 2026) and -$2.53 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Grace Therapeutics | 32.81 Mn | -33.45 Mn | - | -15.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.92 Mn |
| Mar 31, 2026 | -3.01 Mn |
| Dec 31, 2025 | -2.45 Mn |
| Sep 30, 2025 | -2.53 Mn |
| Jun 30, 2025 | -3.09 Mn |
| Mar 31, 2025 | -3.18 Mn |
| Dec 31, 2024 | -3.70 Mn |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -4.96 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -3.04 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -4.45 Mn |
| Mar 31, 2023 | -38.07 Mn |
| Dec 31, 2022 | -4.25 Mn |
| Sep 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -4.73 Mn |
| Mar 31, 2022 | -4.40 Mn |
| Dec 31, 2021 | -4.47 Mn |
| Sep 30, 2021 | -3.57 Mn |
API Access
Grace Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();